Evidence map›Paper›PMID 16912314›Full record

ArticleJournal of virology2006

Characterization of a UL49-null mutant: VP22 of herpes simplex virus type 1 facilitates viral spread in cultured cells and the mouse cornea.

Carol Duffy, Jennifer H Lavail, Andrew N Tauscher, Elizabeth G Wills, John A Blaho, Joel D Baines

Abstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carol DuffyDepartment of Microbiology and Immunology, Cornell University, Ithaca, NY 14853, USA.
Jennifer H Lavail
Andrew N Tauscher
Elizabeth G Wills
John A Blaho
Joel D Baines

Funding

Nucleocapsid Envelopment Herpes Simplex Virus-1R01AI052341 · NIAID · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI BAINES, JOEL D. · 2003 to 2013
$3.6M
HERPES SIMPLEX VIRUS TERMINASESR01GM050740 · NIGMS · CORNELL UNIVERSITY ITHACA · PI BAINES, JOEL D. · 1995 to 2007
$2.3M
HSV REGULATION BY PROTEIN MODIFICATIONR01AI038873 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BLAHO, JOHN A. · 2002 to 2006
$1.5M
HSV and Host Cell Contributions to Corneal InfectionR01EY013867 · NEI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LAVAIL, JENNIFER HART · 2002 to 2005
$1.1M
HSV REGULATION BY PROTEIN MODIFICATIONR21AI038873 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BLAHO, JOHN A. · 2001 to 2001
$339k
Herpes Simplex Virus TerminasesR56GM050740 · NIGMS · CORNELL UNIVERSITY · PI BAINES, JOEL D. · 2008 to 2008
$323k
HSV PROTEIN NUCLEOTIDYLATION AND LYTIC INFECTIONR29AI038873 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BLAHO, JOHN A. · 1996 to 2000
$117k
The Role of ATP Hydrolysis in HSV-1 Terminase ActivityF32GM067519 · NIGMS · CORNELL UNIVERSITY ITHACA · PI DUFFY, CAROL LYNN · 2003 to 2004
$99k
NEI NIH HHS EY 13867NEI NIH HHS R01 EY013867NIAID NIH HHS AI 38873NIAID NIH HHS AI 52341NIAID NIH HHS R01 AI038873NIAID NIH HHS R01 AI052341NIAID NIH HHS R21 AI038873NIAID NIH HHS R29 AI038873NIGMS NIH HHS F32 GM067519NIGMS NIH HHS R01 GM050740NIGMS NIH HHS R01 GM 50740NIGMS NIH HHS R56 GM050740
6 · The paper itself

Abstract

Herpes simplex virus type 1 (HSV-1) virions, like those of all herpesviruses, contain a proteinaceous layer termed the tegument that lies between the nucleocapsid and viral envelope. The HSV-1 tegument is composed of at least 20 different viral proteins of various stoichiometries. VP22, the product of the U(L)49 gene, is one of the most abundant tegument proteins and is conserved among the alphaherpesviruses. Although a number of interesting biological properties have been attributed to VP22, its role in HSV-1 infection is not well understood. In the present study we have generated both a U(L)49-null virus and its genetic repair and characterized their growth in both cultured cells and the mouse cornea. While single-step growth analyses indicated that VP22 is dispensable for virus replication at high multiplicities of infection (MOIs), analyses of plaque morphology and intra- and extracellular multistep growth identified a role for VP22 in viral spread during HSV-1 infection at low MOIs. Specifically, VP22 was not required for either virion infectivity or cell-cell spread but was required for accumulation of extracellular virus to wild-type levels. We found that the absence of VP22 also affected virion composition. Intracellular virions generated by the U(L)49-null virus contained reduced amounts of ICP0 and glycoproteins E and D compared to those generated by the wild-type and U(L)49-repaired viruses. In addition, viral spread in the mouse cornea was significantly reduced upon infection with the U(L)49-null virus compared to infection with the wild-type and U(L)49-repaired viruses, identifying a role for VP22 in viral spread in vivo as well as in vitro.

Indexed as

Gene DeletionAnimalsChlorocebus aethiopsCorneaHerpesvirus 1, HumanKeratitis, HerpeticMaleMiceMice, Inbred BALB CPlasmidsVero CellsViral Structural ProteinsVirionVirus Replicationherpes simplex virus type 1 protein VP22Viral Structural Proteins

Identifiers

PMID16912314
PMCPMC1563855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.